F S&P 500
5,562.75 +16.75 (+0.30%) F Dow Jones
39,561.00 +11.00 (+0.03%) F Nasdaq
20,135.75 +96.25 (+0.48%) E-mini Russell 2000 Index Futur
2,068.70 +8.60 (+0.42%) Petróleo
82.20 +0.46 (+0.56%) Oro
2,332.30 -4.30 (-0.18%)
Medical Developments International Limited (MDDVF)
Medical Developments International Limited
4 Caribbean Drive
Scoresby, VIC 3179
Australia
61 3 9547 1888
https://medicaldev.com
Sector(es): Healthcare
Industria: Drug Manufacturers - Specialty & Generic
Empleados a tiempo completo:
Ejecutivos clave
| Nombre | Título | Pagar | Ejecutado | Año de nacimiento |
|---|---|---|---|---|
| Mr. Brent MacGregor | Chief Executive Officer | 503.96k | N/D | 1964 |
| Ms. Anita James | Chief Financial Officer | 285.91k | N/D | N/D |
| Matthew Cramer | Chief of Operations & Supply Chain | N/D | N/D | N/D |
| Ms. Tara Eaton | General Counsel & Company Secretary | N/D | N/D | N/D |
| Dr. Scott Courtney | Chief Scientific Officer | N/D | N/D | N/D |
| Wai Ng Chi | Head of Regulatory Affairs | N/D | N/D | N/D |
| Wayne Pearce | Head of Production | N/D | N/D | N/D |
| Mr. Stefaan Schatteman | Head of Europe | N/D | N/D | N/D |
Descripción
Medical Developments International Limited manufactures and distributes emergency medical solutions in Australia, Europe, the United States, and internationally. The company operates through Pain Management and Respiratory segments. It offers respiratory devices for sufferers of asthma and chronic obstructive pulmonary disease (COPD); and Penthrox, a trauma and emergency pain relief product; and medical devices. The company also provides asthma and COPD products, such as space chambers and silicone face masks. The company was founded in 1971 and is headquartered in Scoresby, Australia.
Gestión corporativa
La calificación ISS Governance QuickScore de Medical Developments International Limited a partir del 1 de junio de 2024 es 4. Las puntuaciones principales son Auditoría: 5; Junta: 3; Derechos del accionista: 1; Compensación: 8.
